Dimensional Fund Advisors
PYXS icon

Dimensional Fund Advisors’s Pyxis Oncology PYXS Stock Holding History

Dimensional Fund Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
36,175
+10,263
+40% +$19.6K ﹤0.01% 3134
2026
Q1 		$37.8K Sell
25,912
-24,154
-48% -$36.4K ﹤0.01% 3190
2025
Q4 		$57.6K Buy
50,066
+13,550
+37% +$47.8K ﹤0.01% 3203
2025
Q3 		$81.1K Hold
36,516
– – ﹤0.01% 3210
2025
Q2 		$40.2K Hold
36,516
– – ﹤0.01% 3247
2025
Q1 		$35.8K Sell
36,516
-74,535
-67% -$99.4K ﹤0.01% 3276
2024
Q4 		$173K Buy
111,051
+29,105
+36% +$83.9K ﹤0.01% 3181
2024
Q3 		$301K Buy
81,946
+12
+0% +$42 ﹤0.01% 3110
2024
Q2 		$271K Sell
81,934
-19,876
-20% -$83.6K ﹤0.01% 3118
2024
Q1 		$434K Hold
101,810
– – ﹤0.01% 3069
2023
Q4 		$183K Sell
101,810
-51,961
-34% -$89K ﹤0.01% 3206
2023
Q3 		$306K Buy
153,771
+136,281
+779% +$316K ﹤0.01% 3137
2023
Q2 		$44.8K Buy
17,490
+5,403
+45% +$17.1K ﹤0.01% 3416
2023
Q1 		$48.5K Buy
+12,087
New +$24.1K ﹤0.01% 3388

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors's PYXS Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Pyxis Oncology (PYXS) stake by 40% in Q2 2026, buying an estimated $19.6K and bringing the position to 36,175 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3134.

Dimensional Fund Advisors first reported a position in PYXS in Q1 2023 and has held it in 14 quarters since. The position peaked at $434K in Q1 2024. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Dimensional Fund Advisors held 36,175 shares of Pyxis Oncology worth $109K as of Q2 2026.
  • Dimensional Fund Advisors bought 10,263 Pyxis Oncology shares in Q2 2026, an estimated $19.6K.
  • Pyxis Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3134 holding.
  • Dimensional Fund Advisors first reported a position in Pyxis Oncology in Q1 2023 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Pyxis Oncology position peaked at $434K in Q1 2024.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.